Glaxosmithkline Share News (GSK)

Tuesday broker round-up UPDATE

Abderdeen Asset Management: Berenberg cuts target price from 530p to 510p and maintains a buy recommendation. African Barrick Gold: Numis takes target price from 260p to 330p upgrading from hold to buy. Anglo American: Deutsche Bank increases target price from 1590p to 1650p and reiterates a hold

UK BROKER RATINGS: Numis Raises GKN To Buy From Add

Tuesday tips round-up: Hiscox, Reckitt Benckiser, GlaxoSmithKline

Insurance outfit Hiscox is one of the most respected names in its sector and for good reason. For the first half of the year the outfit achieved a combined ratio of 82%. That marks a deterioration on the 74.7% seen in the comparable period of the year before but is nevertheless a good result. The co

Shanghai court says trial of GSK-linked investigators set for Aug 8

SHANGHAI, July 29 (Reuters) - The public trial of a foreign couple linked to GlaxoSmithKline Plc (GSK) is set for Aug. 8, a Shanghai court said on Tuesday. Earlier this month, Chinese prosecutors accused British investigator Peter Humphrey and his American wife Yu Yingzeng for illegally obt

London close: Traders bide their time ahead of US jobs data

- BskyB paces gains - Lloyds fined $370m by UK and US authorities - Aberdeen Asset Management sees slight drop in AuM techMARK 2,776.05 -0.83% FTSE 100 6,788.07 -0.05% FTSE 250 15,616.53 -0.48% The Footsie finished the session slightly lower as traders bided their time ahead of a raft of key data

MEDIA-FBI, SEC probing Glaxo over China bribery scandal - WSJ

-- Source link: (http://on.wsj.com/1nRdCKp) -- Note: Reuters has not verified this story and does not vouch for its accuracy

UK MIDDAY BRIEFING: Aberdeen Slumps As Withdrawal Hits Assets

Monday broker round-up UPDATE

African Barrick Gold: UBS ups target price from 260p to 290p and maintains a buy recommendation. Deutsche Bank cuts target price from 300p to 280p and reiterates a buy recommendation. Anglo American: UBS downgrades from buy to neutral with a target price of 1700p. Barclays: Nomura cuts target pric

TOP NEWS: Reckitt Benckiser Will Spin Off Pharmaceutical Arm

GlaxoSmithKline may spin off consumer healthcare arm - report

British drug giant GlaxoSmithKline may spin off its consumer health division as it tries to get to grips with increasing competition for its drugs and Chinese bribery allegations, it was reported on Monday. Glaxo may demerge the business, which includes brands such as Aquafresh toothpaste, Panadol

London open: Stocks in holding pattern ahead of key data

- GSK break-up possibly on the cards - RyanAir reports doubling of first quarter profits - Aberdeen Asset Management sees slight drop in AuM techMARK 2,794.05 -0.19% FTSE 100 6,800.81 +0.14% FTSE 250 15,661.43 -0.19% The Footsie was trading little changed early on in the session, ahead of what was

UK MORNING BRIEFING: UK Shares Mixed At Open; RBS Is Upgraded

MARKET COMMENT: UK Shares Set To Start Week On Front Foot

PRESS: Glaxo Has Option To Separate Consumer Healthcare Business - The Financial Times

MEDIA-GSK opens issue of spinning off consumer division -FT

-- Source link: (http://on.ft.com/WZTtbv) -- Note: Reuters has not verified this story and does not vouch for its accuracy